FindTrial
Sign In

The influence of 20-hydroxyeicosapentaenoic acid (20-HETE) on renal function and renal hemodynamics in patients with sepsis-associated acute kidney injury

The influence of 20-hydroxyeicosapentaenoic acid (20-HETE) on renal function and renal hemodynamics in patients with sepsis-associated acute kidney injury

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500106881
Enrollment
Unknown
Registered
2025-07-31
Start date
2025-08-01
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sepsis

Interventions

Observation Group:None

Sponsors

The Fourth Hospital of Hebei Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Adult patients with a definite diagnosis of sepsis (diagnostic criteria: Sepsis 3.0) with or without acute kidney injury at the study center

Exclusion criteria

Exclusion criteria: 1.ICU Length of hospital stay 123.8 µmol/L, estimated glomerular filtration rate (eGFR) < 60 mL·min-1·1.73 m-2]; 3. Acute kidney injury at the time of admission to the ICU; 4. Pregnant women; 5. Patients who have not signed the informed consent form or have incomplete clinical data.

Design outcomes

Primary

MeasureTime frame
Renal blood flow;Renal elastography;—

Countries

China

Contacts

Public ContactHan Yaqi

The Fourth Hospital of Hebei Medical University

guanyi_hebei@163.com+86 185 3316 9618

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026